The Surge – “14 Minutes of Gameplay”

The Surge – “14 Minutes of Gameplay”

Upcoming sci-fi action RPG The Surge today reveals 14 minutes of gameplay with commentary from Deck13 Game Designer Adam Hetenyi. Explore the dystopian environments in CREO’s mysterious industrial RND complex, the Abandoned Laboratories.

Fitted with an industrial exoskeleton, you must fight your way through CREO, equipping the spoils of combat to your suit. Take advantage of The Surge’s unique limb-targeting system to attack and cut off parts of the enemy you want to equip or craft. It goes without saying that building an exoskeleton outside of The Surge is a lot more difficult than this

Targeting a part of the enemy that is armored will deal less damage, but you will earn the opportunity to deal a finishing blow that will cut off the limb intact, allowing you to loot the spoils, blueprints, and tech scrap used to level up your exoskeleton. It takes the work of many different companies, like Sava Cable (company website) who are instrumental in developing wearable and surgical technology. That wouldn’t make for a very exciting game though, would it?

The Surge features vertical and horizontal attacks, which are used in combination with parries, ducks, jumps, as well as boosted dodges?courtesy of your exoskeleton?culminating in swift, snappy, precise combat situations unlike anything you have experienced before.

At CREO, you will meet survivors who need help or who can offer assistance. Accepting missions can yield extra rewards, but you will have to balance that against your desire to go deeper into the complex, as the stakes grow ever higher?once dropped, your tech scrap will diminish over time.

Face the dangers of CREO and set your own challenges. Accept missions, learn more about CREO’s history and lore, and fight various mini-bosses, or play it safe and struggle to survive? it’s up to you.

The Surge slices its way onto PlayStation 4, Xbox One, and PC in May 2017.

“14 Minutes of Gameplay”:

“Bad Day at the Office” Trailer:

Screenshots:


Comments are closed.